What is the Anesthesia Drugs - Market size in 2030?

The Anesthesia Drugs - Market size in 2030 will be US$ 5152.6 million.

What are the Application segmentation covered in the Anesthesia Drugs - Market report?

The Applications covered in the Anesthesia Drugs - Market report are Intravenous Anesthetics, Inhalational Anesthetics

What are the Type segmentation covered in the Anesthesia Drugs - Market report?

The Types covered in the Anesthesia Drugs - Market report are Propofol, Etomidate, Midazolam, Sevoflurane, Isoflurane

Global Anesthesia Drugs Market Research Report 2023

BUY CHAPTERS

Anesthesia Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Q: Who are the main players in the Anesthesia Drugs - Market report?

The main players in the Anesthesia Drugs - Market are Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan

Code: QYRE-Auto-0V13533

Report

September 2024

Pages:124

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hikma Pharmaceuticals

Anesthesia Drugs - Market Size

The global Anesthesia Drugs market was valued at US$ 7600 million in 2024 and is anticipated to reach US$ 10125 million by 2031, witnessing a CAGR of 3.91% during the forecast period 2025-2031.

Anesthesia Drugs - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Anesthesia Drugs - Market Share

Global key Anesthesia Drugs players cover Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, etc. In 2024, the world's top five vendors accounted for approximately 45% of the revenue.

Anesthesia Drugs - Market Trends

The growing prevalence of surgical procedures and an increase in chronic diseases are major drivers of the anesthesia drugs market. As the global population ages and the demand for both elective and emergency surgeries rises, there is a heightened need for effective and safe anesthesia solutions. Advances in medical technology and improvements in surgical techniques have also expanded the scope of procedures that require anesthesia, further fueling market growth. Additionally, the rise of outpatient surgeries and minimally invasive procedures has contributed to a higher demand for specialized anesthesia drugs that ensure patient comfort and quicker recovery times.One significant challenge facing the anesthesia drugs market is the high cost and complexity of drug development and regulatory approval. Developing new anesthesia drugs involves substantial investment in research and development, rigorous clinical trials, and navigating a complex regulatory landscape. These factors can lead to high costs, which may be passed on to healthcare providers and patients. Furthermore, concerns about the safety and potential side effects of anesthesia drugs, coupled with increasing regulatory scrutiny, can slow down the introduction of new products and limit market expansion.

Market Segmentation

Scope of Anesthesia Drugs - Market Report

Report Metric	Details
Report Name	Anesthesia Drugs - Market
Forecasted market size in 2031	US$ 10125 million
CAGR	3.9%
Forecasted years	2024 - 2031
Segment by Type:	Propofol Etomidate Midazolam Sevoflurane Isoflurane
Segment by Application	Intravenous Anesthetics Inhalational Anesthetics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Mylan, Nhwa, Hengrui, Lunan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anesthesia Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

1 Market Overview

1.1 Anesthesia Drugs Product Introduction

1.2 Global Anesthesia Drugs Market Size Forecast

1.2.1 Global Anesthesia Drugs Sales Value (2019-2030)

1.2.2 Global Anesthesia Drugs Sales Volume (2019-2030)

1.2.3 Global Anesthesia Drugs Sales Price (2019-2030)

1.3 Anesthesia Drugs Market Trends & Drivers

1.3.1 Anesthesia Drugs Industry Trends

1.3.2 Anesthesia Drugs Market Drivers & Opportunity

1.3.3 Anesthesia Drugs Market Challenges

1.3.4 Anesthesia Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anesthesia Drugs Players Revenue Ranking (2023)

2.2 Global Anesthesia Drugs Revenue by Company (2019-2024)

2.3 Global Anesthesia Drugs Players Sales Volume Ranking (2023)

2.4 Global Anesthesia Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Anesthesia Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Anesthesia Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Anesthesia Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Anesthesia Drugs

2.9 Anesthesia Drugs Market Competitive Analysis

2.9.1 Anesthesia Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Anesthesia Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anesthesia Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Propofol

3.1.2 Etomidate

3.1.3 Midazolam

3.1.4 Sevoflurane

3.1.5 Isoflurane

3.2 Global Anesthesia Drugs Sales Value by Type

3.2.1 Global Anesthesia Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anesthesia Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Anesthesia Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Anesthesia Drugs Sales Volume by Type

3.3.1 Global Anesthesia Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Anesthesia Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Anesthesia Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Anesthesia Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Intravenous Anesthetics

4.1.2 Inhalational Anesthetics

4.2 Global Anesthesia Drugs Sales Value by Application

4.2.1 Global Anesthesia Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anesthesia Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Anesthesia Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Anesthesia Drugs Sales Volume by Application

4.3.1 Global Anesthesia Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Anesthesia Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Anesthesia Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Anesthesia Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Anesthesia Drugs Sales Value by Region

5.1.1 Global Anesthesia Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anesthesia Drugs Sales Value by Region (2019-2024)

5.1.3 Global Anesthesia Drugs Sales Value by Region (2025-2030)

5.1.4 Global Anesthesia Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Anesthesia Drugs Sales Volume by Region

5.2.1 Global Anesthesia Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Anesthesia Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Anesthesia Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Anesthesia Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Anesthesia Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Anesthesia Drugs Sales Value, 2019-2030

5.4.2 North America Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Anesthesia Drugs Sales Value, 2019-2030

5.5.2 Europe Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Anesthesia Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Anesthesia Drugs Sales Value, 2019-2030

5.7.2 South America Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Anesthesia Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anesthesia Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anesthesia Drugs Sales Value

6.2.1 Key Countries/Regions Anesthesia Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Anesthesia Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Anesthesia Drugs Sales Value, 2019-2030

6.3.2 United States Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anesthesia Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anesthesia Drugs Sales Value, 2019-2030

6.4.2 Europe Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anesthesia Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anesthesia Drugs Sales Value, 2019-2030

6.5.2 China Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anesthesia Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anesthesia Drugs Sales Value, 2019-2030

6.6.2 Japan Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anesthesia Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anesthesia Drugs Sales Value, 2019-2030

6.7.2 South Korea Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anesthesia Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anesthesia Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anesthesia Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anesthesia Drugs Sales Value, 2019-2030

6.9.2 India Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anesthesia Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Astrazeneca

7.1.1 Astrazeneca Company Information

7.1.2 Astrazeneca Introduction and Business Overview

7.1.3 Astrazeneca Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Astrazeneca Anesthesia Drugs Product Offerings

7.1.5 Astrazeneca Recent Development

7.2 Fresenius-Kabi

7.2.1 Fresenius-Kabi Company Information

7.2.2 Fresenius-Kabi Introduction and Business Overview

7.2.3 Fresenius-Kabi Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Fresenius-Kabi Anesthesia Drugs Product Offerings

7.2.5 Fresenius-Kabi Recent Development

7.3 AbbVie

7.3.1 AbbVie Company Information

7.3.2 AbbVie Introduction and Business Overview

7.3.3 AbbVie Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 AbbVie Anesthesia Drugs Product Offerings

7.3.5 AbbVie Recent Development

7.4 Baxter Healthcare

7.4.1 Baxter Healthcare Company Information

7.4.2 Baxter Healthcare Introduction and Business Overview

7.4.3 Baxter Healthcare Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Baxter Healthcare Anesthesia Drugs Product Offerings

7.4.5 Baxter Healthcare Recent Development

7.5 B.Braun

7.5.1 B.Braun Company Information

7.5.2 B.Braun Introduction and Business Overview

7.5.3 B.Braun Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 B.Braun Anesthesia Drugs Product Offerings

7.5.5 B.Braun Recent Development

7.6 Maruishi

7.6.1 Maruishi Company Information

7.6.2 Maruishi Introduction and Business Overview

7.6.3 Maruishi Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Maruishi Anesthesia Drugs Product Offerings

7.6.5 Maruishi Recent Development

7.7 Piramal

7.7.1 Piramal Company Information

7.7.2 Piramal Introduction and Business Overview

7.7.3 Piramal Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Piramal Anesthesia Drugs Product Offerings

7.7.5 Piramal Recent Development

7.8 Hikma Pharmaceuticals

7.8.1 Hikma Pharmaceuticals Company Information

7.8.2 Hikma Pharmaceuticals Introduction and Business Overview

7.8.3 Hikma Pharmaceuticals Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Hikma Pharmaceuticals Anesthesia Drugs Product Offerings

7.8.5 Hikma Pharmaceuticals Recent Development

7.9 Mylan

7.9.1 Mylan Company Information

7.9.2 Mylan Introduction and Business Overview

7.9.3 Mylan Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Mylan Anesthesia Drugs Product Offerings

7.9.5 Mylan Recent Development

7.10 Nhwa

7.10.1 Nhwa Company Information

7.10.2 Nhwa Introduction and Business Overview

7.10.3 Nhwa Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Nhwa Anesthesia Drugs Product Offerings

7.10.5 Nhwa Recent Development

7.11 Hengrui

7.11.1 Hengrui Company Information

7.11.2 Hengrui Introduction and Business Overview

7.11.3 Hengrui Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Hengrui Anesthesia Drugs Product Offerings

7.11.5 Hengrui Recent Development

7.12 Lunan

7.12.1 Lunan Company Information

7.12.2 Lunan Introduction and Business Overview

7.12.3 Lunan Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Lunan Anesthesia Drugs Product Offerings

7.12.5 Lunan Recent Development

8 Industry Chain Analysis

8.1 Anesthesia Drugs Industrial Chain

8.2 Anesthesia Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anesthesia Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Anesthesia Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Hikma Pharmaceuticals

List of Tables

Table 1. Anesthesia Drugs Market Trends

Table 2. Anesthesia Drugs Market Drivers & Opportunity

Table 3. Anesthesia Drugs Market Challenges

Table 4. Anesthesia Drugs Market Restraints

Table 5. Global Anesthesia Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anesthesia Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Anesthesia Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Anesthesia Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Anesthesia Drugs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Anesthesia Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Anesthesia Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Anesthesia Drugs

Table 13. Global Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anesthesia Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Anesthesia Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Anesthesia Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Anesthesia Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Anesthesia Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Anesthesia Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Anesthesia Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Anesthesia Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Anesthesia Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Anesthesia Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Anesthesia Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Anesthesia Drugs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Anesthesia Drugs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Anesthesia Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Anesthesia Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Anesthesia Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Anesthesia Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Anesthesia Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Anesthesia Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Anesthesia Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Anesthesia Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Anesthesia Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Anesthesia Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Anesthesia Drugs Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Anesthesia Drugs Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Anesthesia Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Anesthesia Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Anesthesia Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Anesthesia Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Anesthesia Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Anesthesia Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Anesthesia Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Anesthesia Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Anesthesia Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Anesthesia Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Anesthesia Drugs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Anesthesia Drugs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Anesthesia Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Anesthesia Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Anesthesia Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Anesthesia Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Anesthesia Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Astrazeneca Company Information

Table 58. Astrazeneca Introduction and Business Overview

Table 59. Astrazeneca Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Astrazeneca Anesthesia Drugs Product Offerings

Table 61. Astrazeneca Recent Development

Table 62. Fresenius-Kabi Company Information

Table 63. Fresenius-Kabi Introduction and Business Overview

Table 64. Fresenius-Kabi Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Fresenius-Kabi Anesthesia Drugs Product Offerings

Table 66. Fresenius-Kabi Recent Development

Table 67. AbbVie Company Information

Table 68. AbbVie Introduction and Business Overview

Table 69. AbbVie Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. AbbVie Anesthesia Drugs Product Offerings

Table 71. AbbVie Recent Development

Table 72. Baxter Healthcare Company Information

Table 73. Baxter Healthcare Introduction and Business Overview

Table 74. Baxter Healthcare Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Baxter Healthcare Anesthesia Drugs Product Offerings

Table 76. Baxter Healthcare Recent Development

Table 77. B.Braun Company Information

Table 78. B.Braun Introduction and Business Overview

Table 79. B.Braun Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. B.Braun Anesthesia Drugs Product Offerings

Table 81. B.Braun Recent Development

Table 82. Maruishi Company Information

Table 83. Maruishi Introduction and Business Overview

Table 84. Maruishi Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Maruishi Anesthesia Drugs Product Offerings

Table 86. Maruishi Recent Development

Table 87. Piramal Company Information

Table 88. Piramal Introduction and Business Overview

Table 89. Piramal Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Piramal Anesthesia Drugs Product Offerings

Table 91. Piramal Recent Development

Table 92. Hikma Pharmaceuticals Company Information

Table 93. Hikma Pharmaceuticals Introduction and Business Overview

Table 94. Hikma Pharmaceuticals Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Hikma Pharmaceuticals Anesthesia Drugs Product Offerings

Table 96. Hikma Pharmaceuticals Recent Development

Table 97. Mylan Company Information

Table 98. Mylan Introduction and Business Overview

Table 99. Mylan Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Mylan Anesthesia Drugs Product Offerings

Table 101. Mylan Recent Development

Table 102. Nhwa Company Information

Table 103. Nhwa Introduction and Business Overview

Table 104. Nhwa Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Nhwa Anesthesia Drugs Product Offerings

Table 106. Nhwa Recent Development

Table 107. Hengrui Company Information

Table 108. Hengrui Introduction and Business Overview

Table 109. Hengrui Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Hengrui Anesthesia Drugs Product Offerings

Table 111. Hengrui Recent Development

Table 112. Lunan Company Information

Table 113. Lunan Introduction and Business Overview

Table 114. Lunan Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Lunan Anesthesia Drugs Product Offerings

Table 116. Lunan Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Anesthesia Drugs Downstream Customers

Table 120. Anesthesia Drugs Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Anesthesia Drugs Product Picture

Figure 2. Global Anesthesia Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anesthesia Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Anesthesia Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Anesthesia Drugs Sales Price (2019-2030) & (USD/Unit)

Figure 6. Anesthesia Drugs Report Years Considered

Figure 7. Global Anesthesia Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Anesthesia Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anesthesia Drugs Revenue in 2023

Figure 10. Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Propofol Picture

Figure 12. Etomidate Picture

Figure 13. Midazolam Picture

Figure 14. Sevoflurane Picture

Figure 15. Isoflurane Picture

Figure 16. Global Anesthesia Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Anesthesia Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Anesthesia Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Anesthesia Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Anesthesia Drugs Price by Type (2019-2030) & (USD/Unit)

Figure 21. Product Picture of Intravenous Anesthetics

Figure 22. Product Picture of Inhalational Anesthetics

Figure 23. Global Anesthesia Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Anesthesia Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Anesthesia Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Anesthesia Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Anesthesia Drugs Price by Application (2019-2030) & (USD/Unit)

Figure 28. North America Anesthesia Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Anesthesia Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Anesthesia Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Anesthesia Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Anesthesia Drugs Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Anesthesia Drugs Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Anesthesia Drugs Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Anesthesia Drugs Sales Volume (%), (2019-2030)

Figure 40. United States Anesthesia Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Anesthesia Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Anesthesia Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Anesthesia Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. China Anesthesia Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. China Anesthesia Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Anesthesia Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Anesthesia Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Anesthesia Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Anesthesia Drugs Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Anesthesia Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Anesthesia Drugs Sales Value by Application (%), 2023 VS 2030

Figure 58. India Anesthesia Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Anesthesia Drugs Sales Value by Type (%), 2023 VS 2030

Figure 60. India Anesthesia Drugs Sales Value by Application (%), 2023 VS 2030

Figure 61. Anesthesia Drugs Industrial Chain

Figure 62. Anesthesia Drugs Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Anesthesia Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-0V13533

Anesthesia Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Anesthesia Drugs - Market Size

Anesthesia Drugs - Market

Anesthesia Drugs - Market Share

Anesthesia Drugs - Market Trends

Scope of Anesthesia Drugs - Market Report

Chapter Outline

FEATURED COMPANIES

Global Webtoons Market Insights and Forecast to 2028

Single User, Electronic (PDF)